Visakhapatnam: Artificial intelligence is transforming the pharmaceutical landscape by accelerating drug discovery, ...

The pharmaceutical industry is entering a transformative era where Artificial Intelligence in Drug Discovery is rapidly moving from experimental to mainstream. With its potential to cut timelines, ...

Syngene International, a global contract research, development and manufacturing organization (CRDMO), is adding a GMP bioconjugation suite at its commercial biologics facility [Unit 3] in Bengaluru.

Google's AI breakthrough in drug discovery suggests novel cancer therapies, highlighting the importance of integrating AI ...

A scientist is addressing a critical roadblock in applying AI to drug discovery, marking a potential breakthrough in the ...

Chemists from the University of Warwick and Monash University have discovered a promising new antibiotic that shows activity ...

The field of oncology continues to confront the formidable challenge of addressing cancer, a leading cause of mortality ...